Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Clinical Trial Site, Cypress, California Clinical Trial Site, Boston, Massachusetts Canada
Clinical Trial Site, Mount Royal Clinical Trial Site, Toronto France
Clinical Trial Site, Bordeaux Clinical Trial Site, Bron Germany
Clinical Trial Site, Homburg Spain
Clinical Trial Site, L'Hospitalet de Llobregat